Skip to main content
Premium Trial:

Request an Annual Quote

Biocius to Move to Larger Facility

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Biocius Life Sciences said today that it has reached a new lease agreement and plans to move into a new corporate headquarters in Wakefield, Mass., in June.

The move from the company's current home in Woburn, Mass., will result in a doubling of its capacity, which the company said is necessary due to increased demand for its RapidFire mass spectrometry product and service offerings.

The new facility, which is located around five miles from the firm's current one and will include an enhanced laboratory and a seminar and training room, will increase the company's contract research screening capabilities by around 50 percent, it said.

"Biocius has started on a growth trajectory and the new facility provides an environment to accommodate our expansion plans," Biocius CEO Jeffrey Leathe said in a statement.

Financial terms of the lease agreement were not released.

The company was formed as a spin-out from Biotrove when that firm was acquired by Life Technologies in late 2009.

The agreement gave Biocius all of Biotrove's intellectual property related to its RapidFire platform, and the employees working at Biotrove with the RapidFire line moved on to Biocius after the acquisition.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.